CTCFL and embryonal carcinoma: In addition to cancer cells, BORIS expression has been detected in some pluripotent cells including human embryonic stem (ES) [13, 44] and embryonal carcinoma (EC) cells (TERA-1, TERA-2, NT2 and NCCIT) [30, 43].